Alpha Cognition Inc. - Common Stock (NQ:ACOG)

5.960 -0.380 (-5.99%)

Streaming Delayed Price Updated: 1:37 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Volume	33,056
Open	6.310
Bid (Size)	5.950 (200)
Ask (Size)	6.110 (300)
Prev. Close	6.340
Today's Range	5.832 - 6.448
52wk Range	3.750 - 11.54
Shares Outstanding	146,925,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study

February 25, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

February 18, 2026

From Alpha Cognition Inc.

Via Business Wire

Performance

YTD	-8.3%	-8.3%
1 Month	+1.2%	+1.2%
3 Month	-2.1%	-2.1%
6 Month	-27.7%	-27.7%
1 Year	+2.2%	+2.2%

More News

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

January 07, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

December 01, 2025

From Alpha Cognition Inc.

Via Business Wire

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

October 15, 2025

Via TheNewswire.com

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025

November 14, 2025

Via Newsfile

Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q3 2025 Revenue Beat and Strong Commercial Progress for ZUNVEYL ↗

November 13, 2025

Via Chartmill

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

November 13, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

October 30, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

October 15, 2025

Via NewMediaWire

Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings

October 14, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

October 06, 2025

From Alpha Cognition Inc.

Via Business Wire

BioMedNewsBreaks — Alpha Cognition Inc. (NASDAQ: ACOG) Prices $35 Million Oversubscribed Public Offering

October 03, 2025

Via Investor Brand Network

Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares

September 30, 2025

From Alpha Cognition Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares

September 30, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

August 28, 2025

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

August 15, 2025

Via Newsfile

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 14, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

August 04, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease

July 29, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer’s Association International Conference

July 08, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury

July 01, 2025

From Alpha Cognition Inc.

Via Business Wire

Frequently Asked Questions

Is Alpha Cognition Inc. - Common Stock publicly traded?

Yes, Alpha Cognition Inc. - Common Stock is publicly traded.

What exchange does Alpha Cognition Inc. - Common Stock trade on?

Alpha Cognition Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Alpha Cognition Inc. - Common Stock?

The ticker symbol for Alpha Cognition Inc. - Common Stock is ACOG on the Nasdaq Stock Market

What is the current price of Alpha Cognition Inc. - Common Stock?

The current price of Alpha Cognition Inc. - Common Stock is 5.960

When was Alpha Cognition Inc. - Common Stock last traded?

The last trade of Alpha Cognition Inc. - Common Stock was at 02/26/26 01:37 PM ET

What is the market capitalization of Alpha Cognition Inc. - Common Stock?

The market capitalization of Alpha Cognition Inc. - Common Stock is 875.67M

How many shares of Alpha Cognition Inc. - Common Stock are outstanding?

Alpha Cognition Inc. - Common Stock has 876M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.